We tested the hypothesis that bone marrow-derived mononuclear cells (BMDMCs) at an early phase of cecal ligation and puncture (CLP)-induced sepsis may have lasting effects on: (1) lung mechanics and histology, (2) the structural remodelling of lung parenchyma, (3) lung, kidney, and liver cell apoptosis, and (4) pro-and anti-inflammatory cytokines and growth factors. At day 1, BMDMC significantly reduced mortality, as well as caspase-3, interleukin (IL)-6 and IL-1␤, vascular endothelial growth factor, plateletderived growth factor, hepatocyte growth factor, and transforming growth factor-␤, but increased IL-10 mRNA expression in lung tissue in septic mice contributing to endothelium and epithelium alveolar repair and improvement of lung mechanics. BMDMC also prevented the increase of apoptotic cells in lung, liver, and kidney. At day 7, these early functional and morphological effects were preserved or further improved. In conclusion, in the present model of sepsis, the beneficial effects of early administration of BMDMCs on lung and distal organs were preserved, possibly by paracrine mechanisms.
Introduction
Several studies have provided preclinical data regarding the therapeutic benefits of mesenchymal stem cells (MSCs) in sepsis (Gonzalez-Rey et al., 2009; Nemeth et al., 2009; Mei et al., 2010) . The administration of MSCs 24 h before and 1 h after surgery has been evaluated in experimental sepsis induced by cecal ligation and puncture (CLP) (Nemeth et al., 2009) , resulting in decreased pro-inflammatory cytokine release, as well as peritoneal, renal, and liver vascular permeability. A further report showed that treatment with human or murine adipose-derived MSCs improved survival and organ dysfunction in a sepsis model (Gonzalez-Rey et al., 2009) . A recently published study (Mei et al., 2010) has also demonstrated that intravenous MSC therapy was effective at reducing systemic and pulmonary inflammation as well as enhancing bacterial clearance, resulting in lower mortality. So far, however, no study in experimental polymicrobial sepsis has elucidated whether the early beneficial effects of cell therapy observed on lung and distal organs were preserved late in the course of injury.
In the current study, we employed bone marrow-derived mononuclear cells (BMDMCs), which are safely administered on the day of harvesting, to test the hypothesis that cell therapy at an early phase of CLP-induced sepsis may have lasting effects on: (1) respiratory mechanics, (2) lung histology, (3) the structural remodelling of lung parenchyma, (4) lung, kidney and liver cell apoptosis, and (5) pro-and anti-inflammatory cytokines and growth factors. These parameters were studied early (one day) and late (seven days) after sepsis induction.
Material and methods
This study was approved by the Ethics Committee of the Health Sciences Centre, Federal University of Rio de Janeiro. All animals received humane care in compliance with the "Principles of Laboratory Animal Care" formulated by the National Society for Medical Research and the "Guide for the Care and Use of Laboratory Animals" prepared by the National Academy of Sciences, USA.
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Extraction and characterization of bone marrow-derived mononuclear cells
Bone marrow cells were extracted from male C57BL/6 (20-25 g, n = 10) and green fluorescent protein (GFP) transgenic mice (20-22 g, n = 4) and administered on the day of collection. Briefly, under anaesthesia with ketamine (25 mg/kg) and xylazine (2 mg/kg) iv, bone marrow cells were aspirated from the femur and tibia by flushing the bone marrow cavity with Dulbecco's modified Eagle's medium (DMEM) (Life Technologies, Grand Island, NY, USA). After a homogeneous cell suspension was achieved, cells were centrifuged (400 × g for 10 min), resuspended in DMEM and added to Ficoll-Hypaque (Histopaque 1083, Sigma Chemical Co., St. Louis, MO, USA). The isolated cells were counted in a Neubauer chamber with Trypan Blue for evaluation of viability. For the administration of saline or BMDMC, mice were anaesthetized with sevoflurane, the jugular vein of each mouse was dissected, and cells were slowly injected. A small aliquot of the mononuclear cells was used for immunophenotipic characterization of the injected cell population. Cell characterization was performed by flow cytometry using antibodies CD45 (leukocyte), CD34 (hematopoietic precursors), CD3, CD8, and CD4 (T lymphocyte), CD14 (monocytes and macrophages), CD11b, CD29 and CD45− (non-hematopoietic precursors), all from BD Biosciences, USA.
Animal preparation and experimental protocol
A total of 106 female C57BL/6 mice (20-25 g) were used. Lung mechanics and histology as well as molecular biology were analyzed in 35 female C57BL/6 mice. The remaining 71 females were used to analyse the survival rate (n = 56) and the number of GFP+ cells in lung tissue (n = 15). All females were randomly assigned to two groups, cecal ligation and puncture (CLP) or Sham. In CLP, polymicrobial sepsis was induced as previously described (Chao et al., 2010) . Briefly, animals were anaesthetized with sevoflurane and a midline laparotomy (2 cm incision) was performed. The cecum was carefully isolated to prevent damage to blood vessels. A 3.0 cotton ligature was placed below the ileocecal valve to prevent bowel obstruction. Finally, the cecum was punctured twice with an 18-gauge needle and the animals recovered from anaesthesia (Chao et al., 2010) . In the Sham group, the abdominal cavity was opened and the cecum was isolated without ligation and puncture. The postoperative period was similar in both cases, with animals receiving subcutaneous injections of 1 ml of warm (37 • C) normal saline with tramadol hydrochloride (20 g/g body weight). At 1 h, the Sham and CLP groups were further randomized into subgroups receiving saline (0.05 ml, SAL) or BMDMC (2 × 10 6 cells/0.05 ml of saline) intravenously (iv) (Fig. 1) .
Survival studies
In order to determine the survival rate, Sham-SAL, Sham-BMDMC, CLP-SAL and CLP-BMDMC (n = 14/group) animals were used. All mice had free access to water and food and were monitored during 7 days by the investigators.
Lung mechanics
At days one and seven, the animals were sedated (diazepam 1 mg ip), anaesthetized (thiopental sodium 20 mg/kg ip), tracheotomised, paralysed (vecuronium bromide, 0.005 mg/kg iv), and ventilated with a constant flow ventilator (Samay VR15; Universidad de la Republica, Montevideo, Uruguay) with the following parameters: frequency of 100 breaths/min, tidal volume (V T ) of 0.2 ml, and fraction of inspired oxygen of 0.21. The anterior chest wall was surgically removed and a positive end-expiratory pres- sure (PEEP) of 2 cm H 2 O was applied. After a 10-min ventilation period, lung mechanics were computed. At the end of the experiments (approximately 30 min), lungs were prepared for histology. Airflow and tracheal pressure (P tr ) were measured (Burburan et al., 2007) . Lung mechanics was analyzed using the end-inflation occlusion method (Bates et al., 1988) . In an open chest preparation, Ptr reflects transpulmonary pressure (P L ). Static lung elastance (E st ) was determined by dividing the elastic recoil pressure of the lung by V T . Lung mechanics measurements were performed 10 times in each animal. All data were analyzed using the ANADAT data analysis software (RHT-InfoData, Inc., Montreal, Quebec, Canada).
Histology
A laparotomy was done immediately after determination of lung mechanics, and heparin (1000 IU) was intravenously injected in the vena cava. The trachea was clamped at end-expiration (PEEP = 2 cm H 2 O), and the abdominal aorta and vena cava were sectioned, yielding a massive haemorrhage that quickly killed the animals. The right lung, liver and kidney were then removed, fixed in 3% buffered formaldehyde and paraffin-embedded. Four-micrometerthick slices were cut and stained with hematoxylin-eosin. Lung morphometry analysis was performed with an integrating eyepiece with a coherent system consisting of a grid with 100 points and 50 lines (known length) coupled to a conventional light microscope (Olympus BX51, Olympus Latin America-Inc., Brazil). Fraction areas of collapsed and normal lung areas were determined by the point-counting technique (Hsia et al., 2010; Weibel, 1990 ) across 10 random, non-coincident microscopic fields (Menezes et al., 2005; Santos et al., 2006; Chao et al., 2010) . Polymorphonuclear (PMN) and mononuclear (MN) cells and lung tissue were evaluated at x 1000 magnification. Points falling on PMN and MN cells were counted, and divided by the total number of points falling on tissue area in each microscopic field. Collagen fibres (picrosiriuspolarization method) were quantified in alveolar septa at 400× magnification (Rocco et al., 2001; Chao et al., 2010) .
Transmission electron microscopy
Three 2 mm × 2 mm × 2 mm slices were cut from three different segments of the left lung and fixed [2.5% glutaraldehyde and phosphate buffer 0.1 M (pH = 7.4)] for electron microscopy (JEOL 1010 Transmission Electron Microscope, Tokyo, Japan) analysis. For each electron microscopy image (20/animal), damage to the following structures was analyzed: (a) type I epithelial cells, (b) type II epithelial cells, (c) basement membrane, (d) alveolar-capillary membrane, and (e) endothelial cells. Pathologic findings were graded according to a 5-point semi-quantitative severity-based scoring system as: 0 = normal lung parenchyma, 1 = changes in 1-25%, 2 = changes in 26-50%, 3 = changes in 51-75%, and 4 = changes in 76-100% of examined tissue (Araújo et al., 2010; Chao et al., 2010) .
Confocal microscopy
For recipients of GFP marrow transplants, frozen sections were treated with 4 ,6-diamidino-2-phenylindole dihydrochloride (DAPI)-supplemented mounting medium (Vectashield, Vector Labs, Burlingame, CA), cover slipped and examined for GFP expression by confocal microscopy. Background autofluorescence was determined through examination of 10 simultaneously prepared negative control sections that were stained with DAPI alone. Images were obtained using a Zeiss LSM-410 laser-scanning confocal microscope (Carl Zeiss Canada Ltd., Toronto, ON, Canada) equipped with GFP (green) and DAPI (blue) filter sets. The number of GFP+ cells per tissue area was determined by the point-counting technique (Weibel, 1990; Araújo et al., 2010; Abreu et al., 2011) across 10 random, non-coincident microscopic fields.
Apoptosis assay of lung and distal organs
Terminal deoxynucleotidyl transferase biotin-dUTP nick end labeling (TUNEL) staining was used in a blinded fashion by two pathologists to assay cellular apoptosis (Oliveira et al., 2009 ). Ten fields per section from the regions with cell apoptosis were examined at a magnification of 400×. A 5-point semi-quantitative severity-based scoring system was used to assess the degree of apoptosis, graded as: 0 = normal lung parenchyma; 1 = 1-25%, 2 = 26-50%, 3 = 51-75%, and 4 = 76-100% of examined tissue.
2.9. Cytokines, growth factors, and caspase-3 mRNA expression Quantitative real-time reverse transcription (RT) polymerase chain reaction (PCR) was performed to measure the relative levels of mRNA expression of vascular interleukin (IL)-1␤, IL-6, IL-10, caspase-3, vascular endothelial growth factor (VEGF), transforming growth factor (TGF)-␤, platelet derived growth factor (PDGF), and hepatocyte growth factor (HGF). Central slices of left lung were cut, collected in cryotubes, quick-frozen by immersion in liquid nitrogen and stored at −80 • C. Total RNA was extracted from the frozen tissues, using Trizol ® reagent (Invitrogen, Carlsbad, CA) according to the manufacturer's recommendations. RNA concentration was measured by spectrophotometry in Nanodrop ® ND-1000. First-strand cDNA was synthesized from total RNA using M-MLV Reverse Transcriptase Kit (Invitrogen, Carlsbad, CA). PCR primers for target gene were purchased (Invitrogen, Carlsbad, CA). Relative mRNA levels were measured with a SYBR green detection system using ABI 7500 Real-Time PCR (Applied Biosystems, Foster City, CA). All samples were measured in triplicate. The relative expression of each gene was calculated as a ratio of studied gene to control gene ( 
Statistical analysis
The normality of the data (Kolmogorov-Smirnov test with Lilliefors' correction) and the homogeneity of variances (Levene median test) were tested. If both conditions were satisfied, differences between the Sham and CLP groups at day 1 were assessed by two-way ANOVA followed by Tukey's test. Since no difference was observed between Sham-SAL and Sham-BMDMC at days 1 and 7 we decided to present only one time point. The comparison between CLP-SAL and CLP-BMDMC groups at days 1 and 7 was performed using one-way ANOVA or one-way ANOVA on ranks for parametric and non-parametric data, respectively. Survival curves were derived by the Kaplan-Meier method and compared by log rank test. Data are presented as mean ± standard error of mean or median (25th-75th percentiles) as appropriate. A p value < 0.05 was considered statistically significant. Statistical analyses were done with SigmaStat 3.1 (Jandel Scientific, San Rafael, CA, USA).
Results

Cell characterization
The following subpopulations were identified from the pool of intravenously injected BMDMCs characterized by flow cytometry: total lymphocyte (CD45+/CD11b−/CD29−/CD34− = 4.2%), T lymphocyte (CD45+/CD3+/CD34−=2.1%), T helper lymphocyte (CD3+/CD4+/CD8− = 0.5%), T cytotoxic lymphocyte (CD3+/CD4−/CD8+ = 1.6%), monocytes (CD45+/CD29+/CD14+/ CD11b−/CD34−/CD3− = 2.8%), neutrophils (CD45+/CD11b+/ CD34−/CD29−/CD14−/CD3− = 78.7%), hematopoietic progenitors (CD34+/CD45+ = 0.5%), and other progenitors cells (CD45− = 9.1%).
Survival rate
At day 7, the survival rate of Sham-SAL and Sham-BMDMC mice was 100%. All animals from the CLP-SAL group died within 48 h after sepsis induction. Therefore, we were unable to provide data for CLP-SAL group at day 7. Survival at days 1 and 7 was higher in the CLP-BMDMC compared to CLP-SAL group (75% vs. 60% and 70% vs. 0%, respectively, P < 0.001) (Fig. 2) .
Lung mechanics
Est,L was higher in CLP-SAL animals compared with Sham-SAL at day 1. BMDMCs led to a significant reduction in Est,L at day 1, whereas at day 7 this reduction was more pronounced (Fig. 3) .
Lung morphometry
The fraction area of alveolar collapse and the number of total, mononuclear and polymorphonuclear cells were higher in CLP-SAL than in Sham-SAL at day 1. BMDMC reduced alveolar collapse at day 1 (from 25% to 16%) with a further reduction at day 7 (from 16% to 11%) in the CLP group (Table 1 and the alveolar septa increased significantly in the CLP-SAL group at day 1. BMDMCs prevented the increase in collagen fibre at day 1; however, at day 7 the collagen fibre content augmented compared to day 1 (Table 1 and Fig. 4) .
Transmission electron microscopy
In CLP-SAL, there was cytoplasmatic degeneration of type II pneumocytes (PII) as well as injury of type I cell, alveolar capillary membrane, and endothelium. At day 1, after BMDMC administration, PII, alveolar-capillary membrane and endothelial cell damage was minimized, with further repair of endothelial cells at day 7 (Table 2 and Fig. 5 ).
Apoptotic cells of lung and distal organs
The number of apoptotic cells in lung, liver and kidney was higher in CLP-SAL compared to Sham-SAL (Table 3) . At days 1 and 7, BMDMCs yielded a reduction in the number of apoptotic cells in lung, kidney, and liver, with no significant changes between days 1 and 7 (Table 3 and Fig. 6 ).
GFP+ cells in lung parenchyma
GFP+ cells were detected in the CLP group both in lung [median (min-max), 5% (2-7)] and kidney [5% (3-9)] at day 1. GFP+ cells were not detected in control lungs or kidneys (Fig. 7) . At day 7, GFP+ cells were no longer detected (Fig. 7) .
3.8. Cytokine, growth factor, and caspase-3 mRNA expression IL-1␤, IL-6, IL-10, caspase-3 (Fig. 8A) , TGF-␤, HGF, PDGF, and VEGF (Fig. 8B ) mRNA expressions were higher in CLP-SAL compared to Sham-SAL. At day 1, BMDMCs reduced IL-1␤, IL-6, caspase-3, TGF-␤, HGF, PDGF, and VEGF mRNA expressions with a further reduction at day 7 in IL-6, caspase-3, PDGF, and VEGF. Conversely, BMDMCs led to a further increase in IL-10 at day 1 with no significant changes at day 7. 
Discussion
In the present murine model of polymicrobial sepsis, early intravenous BMDMC therapy led to, at day 1: (1) improvement in survival rate; (2) a significant reduction in static lung elastance, fraction area of alveolar collapse, number of cells in lung tissue, and collagen fibre content; (3) repair of alveolar epithelium and endothelium; (4) a reduction in cell apoptosis in lung, liver and kidney; (5) low levels of BMDMC persistence in lung and kidney; and (6) decreased expression of caspase-3, IL-6 and IL-1␤, VEGF, PDGF, HGF, and TGF-␤, along with increased expression of IL-10 mRNA in lung tissue. These early functional and morphological beneficial effects were preserved or further improved at day 7.
The CLP model, which leads to polymicrobial infection and gram-negative and positive sepsis, was chosen because it is reproducible and more comparable to human sepsis. Furthermore, it is a good model for abdominal sepsis therapy research (Oliveira et al., 2009; Chao et al., 2010; Mei et al., 2010) .
The mortality in sepsis has been associated with progressive multiple organ failure (Martin et al., 2003; Dellinger et al., 2008) . In this line, the 100% mortality rate 48 h after CLP-sepsis induction (Fig. 2) was related to lung, kidney, and liver damage (Fig. 6 ) (O'Brien et al., 2008) . The lung is one of the first organs to be affected by sepsis; cellular infiltration, and the release of proinflammatory mediators lead to the development of ALI. In this context, at day 1, CLP animals showed increased Est,L, which may be related to the amount of alveolar collapse and neutrophil infiltration, interstitial oedema, and changes in collagen fibre content. Additionally, electron microscopy revealed damaged type II pneumocytes and swelling of lamellar bodies, as well as type I cell and endothelial injury. We also observed that CLP led to apo- Table 3 Cell apoptosis. ptosis ( Fig. 6 and Table 3 ) and cellular activation with increased production of pro-and anti-inflammatory mediators (Fig. 8) . Targeting a single pathway is unlikely to be effective at modulating the complex inflammatory response to sepsis (Rivers et al., 2001; Russell, 2006; O'Brien et al., 2008; Singer, 2008) . For this purpose, immunomodulatory cell therapy has the potential advantage of addressing the complexity of immune abnormalities observed in sepsis and may represent a promising novel treatment strategy affecting the inflammatory response at multiple levels, especially early in the course of sepsis. In this context, MSCs derived from bone marrow (Nemeth et al., 2009; Mei et al., 2010) and adipose tissue (Gonzalez-Rey et al., 2009 ) have led to a reduction in mortality rate and improvement in lung histology, as well as systemic and local inflammatory responses in experimental sepsis. However, MSCs present some disadvantages, such as culture conditions that are detrimental for cell transplantation and the risk of contamination and immunological reactions. Based on these limitations, BMDMCs were chosen in the present study, since they can be easily and safely administered on the day of harvesting, in addition to expressing several genes involved in inflammatory response and chemotaxis as well as presenting lower cost compared to MSCs (Ohnishi et al., 2007) . Furthermore, there is evidence that the number of stem cells trapped inside the lungs is higher following intravenous infusion of BMDMCs compared to MSCs (Fischer et al., 2009) . GFP+ cells were used in order to identify homing of bone marrow cells in lung and kidney parenchyma. To our knowledge, this is the first study that:
(1) investigated the effects of BMDMCs in a model that resembles human sepsis (CLP instead of Escherichia coli lipopolysaccharide); (2) used BMDMCs instead of MSCs; and (3) analyzed whether the early effects of BMDMCs on lung, liver, and kidney are preserved late in the course of injury. The precise mechanisms through which BMDMCs modulate inflammatory responses and gene expression remain to be elucidated. In the current study, bone marrow cell persistence was observed at a low level (<5%) at day 1, while at day 7 no GFP+ cells were detected by confocal microscopy. Similarly, in a previous study of our group, a low number of GFP+ cells were observed in lung parenchyma in extrapulmonary ALI induced by E. coli lipopolysaccharide (Araújo et al., 2010) . Despite the low number of BMDMCs, ultrastructural analysis showed the repair of damaged lungs, suggesting a possible role of paracrine release of trophic factors by, or induced by, BMDMC. In this line, Aslam et al. (2009) demonstrated that the administration MSC-conditioned media was able to reproduce the effects of cell delivery in a hyperoxia induced pulmonary ALI model.
It has been reported that IL-6 and IL-1␤ can regulate neutrophil trafficking during the inflammatory response by orchestrating chemokine production and leukocyte apoptosis (Fielding et al., 2008 ). In the current study, BMDMC therapy yielded a reduction in the level of IL-6 and IL-1␤ at day 1, with a further decrease in IL-6 at day 7 in CLP group, which may result in a decrease in neutrophil infiltration (Fig. 8) . Conversely, IL-10 levels increased after BMDMC administration at days 1 and 7, with no significant differences between early and late time of analysis. IL-10 has been reported to inhibit the rolling, adhesion, and transepithelial migration of neutrophils contributing to reduce the inflammatory process (Perretti et al., 1995) . Similarly, Nemeth et al. (2009) have proposed that the beneficial effects of MSC in experimental CLP induced sepsis were due to the increase in IL-10 production. In contrast, Mei et al. (2010) observed that systemic IL-10 levels were not increased by MSC treatment. These differences may be attributed to the moment of cell administration resulting in a different cytokine profile. In this line, MSCs were delivered 24 h before (Nemeth et al., 2009 ) and 6 h after CLP-induced sepsis (Mei et al., 2010) whereas, in our study, BMDMCs were injected 1 h after sepsis induction. Recently, Toya et al. (2011) showed that progenitor cells derived from human embryonic stem cells ameliorated sepsis-induced lung inflammation and reduced mortality, though these cells did not change the production of IL-10. Thus, not only the moment of cell administration, but also the cell type may contribute to different anti-inflammatory responses. The administration of BMDMC therapy early in the course of the injury yielded a more favourable cytokine profile in the lung, contributing to an efficient control of the inflammatory injury, reducing the amount of alveolar collapse and preventing static lung elastance changes.
Collagen fibre content increased at day 1 in the CLP-SAL group, which may be attributed to the higher degree of alveolar epithelial (Dos Santos, 2008; Rocco et al., 2009 ) and endothelial lesion (Chao et al., 2010) , as well as increased expression of TGF-␤, PDGF, and HGF. These growth factors influence mesenchymal cell migration, extracellular matrix deposition (Adamson et al., 1988; Dos Santos, 2008; Rocco et al., 2009 ) and epithelial repair. TGF-␤ and IL-1␤ also accelerate epithelial wound closure, but the quality of repair may be deregulated (Borthwick et al., 2010) . BMDMC treatment led to a significant reduction in the amount of collagen fibre at day 1. However, at day 7, collagen fibre content was higher than at day 1, which may be attributed to the fact that, even though there was an improvement in lung repair, both epithelial (Santos et al., 2006) and endothelial (Orfanos et al., 2004; Chao et al., 2010) damage (Fig. 5) and TGF-␤, HGF and PDGF expressions (Fig. 8) did not return to normal (Table 2) . Efficient alveolar epithelial repair reduces fibrosis (Santos et al., 2006) because the presence of an intact alveolar epithelial layer suppresses fibroblast # Significantly different from CLP-BMDMC at day 1 (P < 0.05).
proliferation and matrix deposition (Adamson et al., 1988) . Furthermore, BMDMCs may diminish the amount of collagen fibre due to a decrease in the inflammatory process (Araújo et al., 2010) . The current study showed that at day 1, BMDMCs reduced VEGF mRNA expression with a further reduction at day 7 (Fig. 8) , which may yield protective and regenerative effects on pulmonary vascular endothelial cells, reducing vascular permeability (Thickett et al., 2001; Mura et al., 2004) and thus the amount of collagen fibre. Additionally, ensuing fluid exudation may extend the damage to the alveolar epithelial layer, contributing to the fibrogenic process (Lahm et al., 2007; Dos Santos, 2008; Rocco et al., 2009 ). In contrast, Araújo et al. (2010) reported an increase in VEGF following BMDMC therapy in ALI induced by E. coli lipopolysaccharide. These controversial results may be due to: (1) the severity of epithelial and endothelial lesion in ALI induced by CLP compared to E. coli lipopolysaccharide (Chao et al., 2010) , yielding a reduction in VEGF release, (2) the time of BMDMC administration, and (3) the timing of morphological and biochemical analysis.
We observed that CLP-induced sepsis led to increased caspase-3 expression in lung tissue, as well as lung cell apoptosis (Figs. 6 and 8). Caspase-3 is essential for the progression of apoptosis and is involved in the modulation of inflammation, lung fibrosis and its resolution (Hotchkiss and Nicholson, 2006; Bantel and Schulze-Osthoff, 2009; Hattori et al., 2010) . BMDMCs also reduced caspase-3 mRNA expression and the number of lung cell apoptosis at days 1 and 7. Moreover, CLP resulted in increased kidney and liver cell apoptosis, which was decreased after BMDMCs therapy. Accordingly, Mei et al. (2010) described a reduction in the percentage of apoptotic cells in the kidney after treatment with MSCs. BMDMCs prevented the increase of both lung and distal organ apoptotic cells, probably through its paracrine effects, which modulate the release of growth factors and cytokines (Hagimoto et al., 2002; Raffaghello et al., 2008) .
Our study has some limitations that must be addressed: (1) Since all CLP-SAL animals died within 48 h after surgery, we were unable to provide further data at day 7; (2) the present CLP model was limited by the lack of antibiotic use, as occurs in the clinical setting; (3) BMDMCs were used and we do not know whether other types of cells may yield different results than those obtained in the current study; (4) cytokines and growth factors were measured in lung tissue, and thus the balance between bronchoalveolar lavage fluid, peritoneum and blood was not evaluated; and (5) BMDMCs were administered very early in the course of sepsis induction, which may hinder extrapolation to a clinical scenario.
In conclusion, in the present polymicrobial model of abdominal sepsis, the beneficial effects of early administration of BMDMCs on inflammatory and remodelling processes were effectively preserved, contributing to endothelium and epithelium alveolar repair and improvement of lung mechanics, despite the low levels of cell persistence. Thus, the beneficial effects of BMDMCs for the treatment of sepsis may be associated with the balance between growth factors and pro-and anti-inflammatory mediators.
